with febrile respiratory illnesses has yet to be determined. Recent directives from the Ontario Ministry of Health and LongTerm Care (MOHLTC) stipulate the use of, at a minimum, enhanced respiratory and contact precautions (E-RCP), or the use of a personal protective system that combines a powered air-purifying respirator (PAPR) with other protective clothing. 2 The US Center for Disease Control and Prevention (CDC) has recommended the use of personal protective equipment (PPE) when performing or assisting with aerosolgenerating procedures involving patients with SARS.
3
Different personal protective systems have specific donning and removal procedures and might also offer different levels of protection from aerosolized droplets. The PAPR system requires many more steps for donning and removal than E-RCP or PPE. Protective systems that are more complicated to don and remove may expose personnel to an increased risk of self-contamination. The failure of a personal protective system may be associated with health consequences for frontline health care workers. SARS transmission has occurred despite the use of droplet, contact and airborne precautions. 4, 5 A potential explanation for some episodes of "through-precautions" transmission is the possibility of contamination during removal of protective clothing. 6, 7 At present, one study 8 has been published that specifically examined through-gown contamination; another 9 examined the different levels of protection associated with specific facial protective equipment systems. No data have been reported that address the question of self-contamination during the removal of personal protective clothing used in a health care setting.
Our study was performed to examine the difference in selfcontamination rates and the level of contact and droplet protection associated with E-RCP and the PAPR system.
Methods
After obtaining approval from the Queen's University Health Sciences and Affiliated Teaching Hospitals Reasearch Ethics Board, we recruited 50 participants for the study from among the resident and attending staff of the Department of Anesthesiology and practising and student members of the Department of Respiratory Therapy at Kingston General Hospital. They were informed of the purpose of the study, and each gave written consent.
Equipment for the E-RCP and PAPR systems is listed in Table 1 . The CDC recommendations have omitted a head cov-ering as part of their PPE and state that goggles alone can be worn for eye protection. Because the MOHLTC directives stipulate that a head covering, goggles and a face shield must be worn, they were included in E-RCP for this study (Fig. 1 , Table  1 ). The instructions used for donning and removal of E-RCP were an enhanced version of those set out in the MOHLTC directives. The PAPR system in use at our centre has outer and inner protective layers (Fig. 2) .
Participants wore operating-room scrub attire as their base clothing layer. For study purposes, a towel was worn around the neck to protect it during the contamination procedure; this towel does not form part of the protective clothing systems recommended by MOHLTC or CDC. It was placed before donning protective clothing and was worn by members of both study groups. In the crossover design, participants were initially assigned by coin toss to don either the PAPR system or E-RCP garb, then the other personal protective system immediately after completing the removal protocol for the first. All participants were assessed with an ultraviolet (UV) lamp (Burton Medical Products, Van Nuys, Calif.) before donning the protective clothing in order to ensure that no UV fluorescence was present. All traces of surrogate contamination were removed before commencing the process for the second personal protective system. Participants were instructed to don and remove their protective systems at a pace that would allow them to follow correct donning and removal procedures. Participants donning and removing E-RCP followed written instructions only. While donning and removing the PAPR system, however, they were coached by a respiratory therapist referring tp written instructions. Both sets of instructions are available online (at www .cmaj.ca/cgi/content/full/175/3/249/DC1) as Appendix 1 and Appendix 2, respectively.
After donning protective clothing, participants were "contaminated" with a fluorescein solution (1 mL of a 25% solution in 100 mL of sterile water). A Devilbiss atomizer (model DV-15-RD, Sunrise Medical Products, Carlsbad, Calif.) was used to apply 5 mL of solution to each participant's front face shield and torso. "Invisible" Detection Paste (15 mL; Sirchie, Youngsville, NC) was applied from the forearms to the elbow and to the palmar aspects of participants' hands. The paste becomes visible when viewed under UV light.
All participants were timed and videotaped while donning and removing the protective clothing. For participants wearing the PAPR system, timing was paused after removal of the outer protective layer to allow for contamination assessment. Timing ceased when the participants removed the final item of protective clothing.
A donning or removal violation was defined as having occurred if a participant performed a manoeuvre out of sequence, touched an item of clothing out of sequence, tore an item of protective clothing, or touched any body part other than an item of protective clothing before performing the final handwashing step of the protocol.
After removal of the outer protective layer of the PAPR system, participants were assessed by an unblinded observer using a UV lamp. Then, an evaluator blinded to the participants' protective system inspected all areas of subjects' base clothing layer (including the neck-protection towel) and any exposed skin. Contamination of a neck-protection towel was recorded as contamination of the anterior or posterior neck. Areas of contamination were measured.
The primary end point of this study was the presence of contamination on any base clothing or exposed skin. Secondary end points included contamination of the inner layer of the PAPR system, area size on clothing or skin that underwent contamination, number of donning and removal violations, and time required to don and remove the protective systems. Demographic end points consisted of age, height, weight, sex, health care specialty and prior training in the donning and removal of the PAPR system.
Contamination outcomes were compared between systems with the Mainland-Gart test.
10 It was applied by determining, for each subject, which period had a greater area of contamination, and then applying Fisher's exact test to determine if the period with worse contamination was related to the treatment sequence. Thus, subjects with no contamina- Note: E-RCP = enhanced respiratory and contact precautions, PAPR = powered air-purifying respirator, HEPA = high-efficiency particulate air.
tion in either period were excluded. This method is appropriate for crossover studies where a period (learning) effect is possible and the number of subjects in each sequence is unequal. 11, 12 The Mainland-Gart test result is undefined if either period had no event; therefore, in cases where only 1 period had any contamination, we replaced it with McNemar's test. Protocol violations were compared in a similar manner. Donning and removal times were compared between systems with the standard method for 2-period crossover studies with continuous outcomes and a possible learning effect. 10 The area of contamination among subjects with contamination was compared between the 2 systems with the exact Wilcoxon-MannWhitney test. For this tertiary outcome, appropriate methods for paired data were not applicable since the subjects with contamination were not the same for both systems. All p-value calculations were 2-sided; no adjustment was made for multiplicity of end points.
Our study used a convenience sample of 50 clinicians tested once on each system. If we assume that 80% of the subjects in each sequence are contaminated during the use of 1 system at least, and among those contaminated the probability of having more contamination with E-RCP is 75%, then the Mainland-Gart test would provide 87% power at a 2-sided α of 0.05.
Results
Demographic characteristics of the study participants are shown in Table 2 .
Contamination
When the base clothing layer and exposed skin were examined, participants wearing E-RCP were more likely to experience contamination of any size, contamination with an area of 1 cm 2 or more, and a larger total area of contamination when it was present (all p < 0.0001; Table 3 . Individual data are presented in Appendix 3, available online at www.cmaj.ca/cgi /content/full/175/3/249/DC1). The anterior neck and the forearms, hands, and wrists were the zones most likely to be contaminated (Fig. 3) . When the anterior and posterior neck areas were excluded from the analysis, participants wearing E-RCP were still more likely to experience contamination of any size, contamination with an area of 1 cm 2 or more (both p < 0.0001) and a larger total area of contamination (p = 0.013).
When contamination of the PAPR inner layer (Fig. 2 , right panel) was compared to that of the E-RCP base layer or exposed skin (Table 4) , participants wearing E-RCP were more likely to experience contamination of any size, contamination with an
Research Fig. 1 : Enhanced respiratory and contact precautions (E-RCP), familiar to most health care workers. The towel used for neck protection was omitted for illustrative purposes.
Fig. 2:
The other system studied, named for its powered air-purifying respirator (PAPR), has 2 protective layers, shown above. The outer layer (left panel) consists of a hood, fluidresistant surgical gown, shoe covers and 2 pairs of fitted surgical gloves. The inner (right) includes a hooded coverall and shoe covers, PAPR power unit, N95 mask, goggles, bouffant hair cover, and 1 pair of fitted surgical gloves. Contamination assessment for this layer was performed with the PAPR power unit and fitted surgical gloves removed. The towel worn to protect the neck has been omitted for illustrative purposes.
area of 1 cm 2 or more, and a larger total area of contamination (all p < 0.0001). Participants in E-RCP were again more likely to experience contamination of any size and contamination with an area of 1 cm 2 or more (both p < 0.0001) at the anterior neck. When the anterior and posterior neck were excluded from analysis, differences in contamination between the E-RCP base layer and the PAPR inner layer were nonsignificant.
Donning and removal protocol violations
Procedure violations were made by 15 participants during the donning of the PAPR system, versus 2 by those donning E-RCP garb (p = 0.003; Table 5 ). Group differences during protective clothing removal were not significant. In terms of multiple violations, 2 subjects removing E-RCP committed 2 violations; among those wearing PAPR, 4 committed 2 donning violations and 1 committed 2 removal violations. All other participants who violated donning or removal protocols did so only once.
Timing
On average, participants donning PAPR required 6 minutes, 17 seconds (range 222-517 s), whereas those donning E-RCP required 1 minute, 58 seconds (range 64-178 s; p < 0.0001). Participants removing PAPR required 7 minutes, 32 seconds (range 296-667 s), whereas those removing E-RCP required 2 minutes, 15 seconds (range 78-211 s; p < 0.0001).
Interpretation
This study shows that a significantly higher number of participants wearing E-RCP experienced contamination, compared with those wearing the PAPR system. All but 2 participants using E-RCP experienced some degree of contamination at their anterior neck. This appeared to be primarily due to the fluorescein aerosol solution directed at participants' face shields and upper body, as opposed to the detection paste applied to their forearms and hands. When both the anterior and posterior neck were excluded from statistical analysis, subjects wearing E-RCP were still more likely to experience contamination, particularly of their forearms, wrists and hands.
Several reports have already been made of HCWs who wore PPE similar to that recommended by the CDC in highrisk situations yet still contracted SARS. 4, 5 Our study proposes a potential mechanism by which through-precautions transmission of diseases spread by aerosols or respiratory droplets might occur. Most recommendations for decontamination after wearing protective clothing stipulate handwashing. It is conceivable that, despite handwashing, HCWs could proceed Note: E-RCP = enhanced respiratory and contact precautions, PAPR = powered air-purifying respirator, WMW = Wilcoxon-Mann-Whitney test, NA = not applicable, Und. = undefined. *Except where McNemar's test was used, as indicated with asterisks. The Mainland-Gart test was used when contamination occurred during both periods. McNemar's test was substituted when only 1 period had any contamination. Neither test was applied when there was no contamination in either period. †Repeat analysis, in which areas smaller than 1 cm 2 in area were counted as 0 cm. ‡The Wilcoxon-Mann-Whitney test was used to compare the area of contamination for subjects with some contamination. Since these contaminated subjects were different for each system, a test for paired data was not used. to touch other areas of their skin or clothing that have not been adequately decontaminated and then could infect themselves by touching their exposed mucus membranes. Although the PAPR system offered superior protection, it required more time to don and remove it. Despite coaching by another person, a significantly higher number of participants committed violations while donning the PAPR system. Although prior training in the use of personal protective clothing systems might be expected to help address this important issue, our data provided no suggestion of an association between previous PAPR training, time required to don or remove protective clothing systems, donning or removal procedure violations, or the amount of contamination of participants' base clothing or skin.
This study does have several limitations. Fluorescein solution and detection paste, and the areas to which they were applied, were chosen a priori to simulate worst-case viral contamination from respiratory droplets and direct patient contact, respectively. In addition, the definition of "significant contamination area" is unknown; we therefore analyzed our data by treating any contamination as significant. It is notable that, when we repeated our analysis, treating only contamination areas of greater than 1 cm 2 as clinically significant, the difference between the 2 systems persisted. . ‡The Wilcoxon-Mann-Whitney test was used to compare the area of contamination for subjects with some contamination. Since these contaminated subjects were different for each system, a test for paired data was not used.
It was not the intent of our study to examine respiratory contamination that might defeat the N95 (or equivalent) mask that forms a part of both of these personal protective systems.
Despite these limitations, this study provides us with a valuable first step in the examination of the relative effectiveness of protective clothing systems used by HCWs. Future attempts to optimize HCW-protective clothing should involve efforts to find a solution to the different levels of protection associated with specific systems and to improve decontamination procedures. The strengths and limitations of each protective system need to be considered when recommendations are made about which choice of system, donning and removal procedures, and decontamination procedures are optimal for specific clinical situations.
